vatalanib has been researched along with sb 239063 in 2 studies
| Studies (vatalanib) | Trials (vatalanib) | Recent Studies (post-2010) (vatalanib) | Studies (sb 239063) | Trials (sb 239063) | Recent Studies (post-2010) (sb 239063) |
|---|---|---|---|---|---|
| 276 | 42 | 98 | 84 | 0 | 35 |
| Protein | Taxonomy | vatalanib (IC50) | sb 239063 (IC50) |
|---|---|---|---|
| Mitogen-activated protein kinase 13 | Homo sapiens (human) | 0.044 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 0.083 | |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | 0.018 | |
| Protein kinase C alpha type | Homo sapiens (human) | 0.083 | |
| Mitogen-activated protein kinase 9 | Homo sapiens (human) | 0.005 | |
| Mitogen-activated protein kinase 12 | Homo sapiens (human) | 0.044 | |
| Mitogen-activated protein kinase 11 | Homo sapiens (human) | 0.044 | |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | 0.0415 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
| Hajduk, PJ; Johnson, EF; Kifle, L; Merta, PJ; Metz, JT; Soni, NB | 1 |
2 other study(ies) available for vatalanib and sb 239063
| Article | Year |
|---|---|
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |
Navigating the kinome.
Topics: Drug Design; Pharmacogenetics; Protein Kinases; Proteome; Systems Biology | 2011 |